Deficit of in vivo mitochondrial ATP production in OPA1‐related dominant optic atrophy
暂无分享,去创建一个
B. Barbiroli | V. Clementi | P. Barboni | R. Lodi | C. Tonon | E. Malucelli | A. Baruzzi | V. Carelli | B. Wissinger | S. Iotti | M. Valentino | S. Schimpf | L. Longanesi
[1] V. Carelli,et al. Mitochondrial dysfunction as a cause of optic neuropathies , 2004, Progress in Retinal and Eye Research.
[2] J. Parisi,et al. Paraneoplastic autoimmune optic neuritis with retinitis defined by CRMP‐5‐IgG , 2003, Annals of neurology.
[3] G. Lenaers,et al. Loss of OPA1 Perturbates the Mitochondrial Inner Membrane Structure and Integrity, Leading to Cytochrome c Release and Apoptosis* , 2003, The Journal of Biological Chemistry.
[4] A. Schapira,et al. Leber's Hereditary Optic Neuropathy (LHON) Pathogenic Mutations Induce Mitochondrial-dependent Apoptotic Death in Transmitochondrial Cells Incubated with Galactose Medium* , 2003, The Journal of Biological Chemistry.
[5] T. Hamamoto,et al. Differential sublocalization of the dynamin-related protein OPA1 isoforms in mitochondria. , 2003, Biochemical and biophysical research communications.
[6] G. Lenaers,et al. The human dynamin‐related protein OPA1 is anchored to the mitochondrial inner membrane facing the inter‐membrane space , 2002, FEBS letters.
[7] G. Lenaers,et al. OPA1 (Kjer type) dominant optic atrophy: a novel mitochondrial disease. , 2002, Molecular genetics and metabolism.
[8] B. Lorenz,et al. Mutation spectrum and splicing variants in the OPA1 gene , 2001, Human Genetics.
[9] K. Chan,et al. ANNA‐3 anti‐neuronal nuclear antibody: Marker of lung cancer‐related autoimmunity , 2001, Annals of neurology.
[10] D. Manners,et al. No correlation between muscle A3243G mutation load and mitochondrial function in vivo , 2001, Neurology.
[11] M. Magistris,et al. Paraneoplastic anti‐CV2 antibodies react with peripheral nerve and are associated with a mixed axonal and demyelinating peripheral neuropathy , 2001, Annals of neurology.
[12] E. Benarroch,et al. CRMP‐5 neuronal autoantibody: Marker of lung cancer and thymoma‐related autoimmunity , 2001, Annals of neurology.
[13] J. Grosgeorge,et al. Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy , 2000, Nature Genetics.
[14] S. Bhattacharya,et al. OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28 , 2000, Nature Genetics.
[15] B. Barbiroli,et al. 'Secondary' 4216/ND1 and 13708/ND5 Leber's hereditary optic neuropathy mitochondrial DNA mutations do not further impair in vivo mitochondrial oxidative metabolism when associated with the 11778/ND4 mitochondrial DNA mutation. , 2000, Brain : a journal of neurology.
[16] V. Lennon,et al. New Purkinje cell antibody (PCA‐2): Marker of lung cancer–related neurological autoimmunity , 2000, Annals of neurology.
[17] J. Sloan,et al. Neuronal autoantibody titers in the course of small-cell lung carcinoma and platinum-associated neuropathy , 1999, Cancer Immunology, Immunotherapy.
[18] Loise M. Francisco,et al. Tumor-specific killer cells in paraneoplastic cerebellar degeneration , 1998, Nature Medicine.
[19] B. Ducommun,et al. Identification of a fission yeast dynamin-related protein involved in mitochondrial DNA maintenance. , 1998, Biochemical and biophysical research communications.
[20] V. Lennon,et al. Neuronal calcium channel autoantibodies coexisting with type 1 Purkinje cell cytoplasmic autoantibodies (PCA-1 or "anti-Yo") , 1998, Neurology.
[21] V. Lennon,et al. Neuronal nicotinic ACh receptor antibody in subacute autonomic neuropathy and cancer‐related syndromes , 1998, Neurology.
[22] G. Radda,et al. In vivo skeletal muscle mitochondrial function in Leber's hereditary optic neuropathy assessed by 31P magnetic resonance spectroscopy , 1997, Annals of neurology.
[23] E. Dropcho. Antiamphiphysin antibodies with small‐cell lung carcinoma and paraneoplastic encephalomyelitis , 1996, Annals of neurology.
[24] V. Lennon. Calcium Channel and Related Paraneoplastic Disease Autoantibodies , 1996 .
[25] P. Zaniol,et al. Defective brain and muscle energy metabolism shown by in vivo 31P magnetic resonance spectroscopy in nonaffected carriers of 11778 mtDNA mutation , 1995, Neurology.
[26] P. Zaniol,et al. in vivo assessment of mitochondrial functionality in human gastrocnemius muscle by 31P MRS. The role of pH in the evaluation of phosphocreatine and inorganic phosphate recoveries from exercise , 1993, NMR in biomedicine.
[27] A. Engel,et al. Passive transfer of Lambert-Eaton myasthenic syndrome with IgG from man to mouse depletes the presynaptic membrane active zones. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[28] L. Klinken,et al. HISTOPATHOLOGY OF EYE, OPTIC NERVE AND BRAIN IN A CASE OF DOMINANT OPTIC ATROPHY , 1983, Acta ophthalmologica.
[29] V. Smith,et al. A clinicopathologic study of autosomal dominant optic atrophy. , 1979, American journal of ophthalmology.
[30] H A Krebs,et al. Cytosolic phosphorylation potential. , 1979, The Journal of biological chemistry.
[31] P. Kjer. Infantile optic atrophy with dominant mode of inheritance: a clinical and genetic study of 19 Danish families. , 1959, Acta ophthalmologica. Supplementum.